Xu H - Search Results

1

Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability.

Liu D, Xu H, Tian B, Yuan K, Pan H, Ma S, Yang X, Pan W. Liu D, et al. Among authors: xu h. AAPS PharmSciTech. 2012 Mar;13(1):295-304. doi: 10.1208/s12249-011-9750-7. Epub 2012 Jan 13. AAPS PharmSciTech. 2012. PMID: 22246736 Free PMC article.

2

Further investigation of nanostructured lipid carriers as an ocular delivery system: in vivo transcorneal mechanism and in vitro release study.

Tian BC, Zhang WJ, Xu HM, Hao MX, Liu YB, Yang XG, Pan WS, Liu XH. Tian BC, et al. Colloids Surf B Biointerfaces. 2013 Feb 1;102:251-6. doi: 10.1016/j.colsurfb.2012.08.021. Epub 2012 Aug 23. Colloids Surf B Biointerfaces. 2013. PMID: 23006566

3

A novel bi-layer ascending release osmotic pump tablet: in vitro investigation and in vivo investigation in pharmacokinetic study and IVIVC evaluation.

Xu H, Li Z, Pan H, Zhang Z, Liu D, Tian B, Ma S, Song S, Pan W. Xu H, et al. Int J Pharm. 2013 Dec 15;458(1):181-7. doi: 10.1016/j.ijpharm.2013.09.031. Epub 2013 Oct 1. Int J Pharm. 2013. PMID: 24095815

4

Intravenous microemulsion of docetaxel containing an anti-tumor synergistic ingredient (Brucea javanica oil): formulation and pharmacokinetics.

Ma S, Chen F, Ye X, Dong Y, Xue Y, Xu H, Zhang W, Song S, Ai L, Zhang N, Pan W. Ma S, et al. Among authors: xu h. Int J Nanomedicine. 2013;8:4045-52. doi: 10.2147/IJN.S47956. Epub 2013 Oct 25. Int J Nanomedicine. 2013. PMID: 24179332 Free PMC article.

5

In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions.

Tang X, Tai LY, Yang XG, Chen F, Xu HM, Pan WS. Tang X, et al. Drug Dev Ind Pharm. 2013 Jan;39(1):67-76. doi: 10.3109/03639045.2012.657646. Epub 2012 Feb 17. Drug Dev Ind Pharm. 2013. PMID: 22339718

6

Formulation of a stable and high-loaded quercetin injectable emulsion.

Sun H, Xu H, Yang X, Li N, Liu Z, Pan W, Yuan Y. Sun H, et al. Among authors: xu h. Pharm Dev Technol. 2011 Nov-Dec;16(6):609-15. doi: 10.3109/10837450.2010.502899. Epub 2010 Aug 19. Pharm Dev Technol. 2011. PMID: 20718691

7

A novel gastro-floating multiparticulate system for dipyridamole (DIP) based on a porous and low-density matrix core: in vitro and in vivo evaluation.

Li Z, Xu H, Li S, Li Q, Zhang W, Ye T, Yang X, Pan W. Li Z, et al. Among authors: xu h. Int J Pharm. 2014 Jan 30;461(1-2):540-8. doi: 10.1016/j.ijpharm.2013.12.024. Epub 2013 Dec 22. Int J Pharm. 2014. PMID: 24368104

8

Comparison of ¹¹C-Acetate and ¹⁸F-FDG PET/CT for Immune Infiltration and Prognosis in Hepatocellular Carcinoma.

Xu H, Wang H, Jiang DL, Wu YF, Xie SZ, Su YH, Guan YH, Xie F, Zhu WW, Qin LX. Xu H, et al. Cancer Sci. 2025 Jan 11. doi: 10.1111/cas.16449. Online ahead of print. Cancer Sci. 2025. PMID: 39797622

9

Neural Mass Modeling in the Cortical Motor Area and the Mechanism of Alpha Rhythm Changes.

Zhang Y, Li Z, Xu H, Song Z, Xie P, Wei P, Zhao G. Zhang Y, et al. Among authors: xu h. Sensors (Basel). 2024 Dec 25;25(1):56. doi: 10.3390/s25010056. Sensors (Basel). 2024. PMID: 39796846

10

Differential Mitochondrial Redox Responses to the Inhibition of NAD⁺ Salvage Pathway of Triple Negative Breast Cancer Cells.

Kollmar J, Xu J, Gonzalves D, Baur JA, Li LZ, Tchou J, Xu HN. Kollmar J, et al. Among authors: xu hn. Cancers (Basel). 2024 Dec 24;17(1):7. doi: 10.3390/cancers17010007. Cancers (Basel). 2024. PMID: 39796638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,660 results

Search Page

Filters